Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patients
- 31 March 1992
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 41 (3-8), 541-543
- https://doi.org/10.1016/0960-0760(92)90380-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Effect of Tamoxifen on Serum Insulinlike Growth Factor I Levels in Stage I Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1990
- Expression of Two Insulin-Like Growth Factor-Binding Proteins in a Human Endometrial Cancer Cell Line: Structural, Immunological, and Genetic Characterization*Journal of Clinical Endocrinology & Metabolism, 1989
- Insulin-like growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancerCancer, 1989
- Analysis of Insulin-Like Growth Factor I Gene Expression in Malignancy: Evidence for a Paracrine Role in Human Breast CancerMolecular Endocrinology, 1989
- Regulation of Growth Hormone and Somatomedin-C Secretion in Postmenopausal Women: Effect of Physiological Estrogen Replacement*Journal of Clinical Endocrinology & Metabolism, 1986
- 6 Factors controlling blood concentration of somatomedin CClinics in Endocrinology and Metabolism, 1984
- Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancerBritish Journal of Cancer, 1983
- The effect of tamoxifen on plasma growth hormone and prolactin in postmenopausal women with advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1983